Skip to main content
Lippincott Open Access logoLink to Lippincott Open Access
editorial
. 2020 May 19;102(14):1222–1229. doi: 10.2106/JBJS.20.00363

What’s New in Musculoskeletal Infection

Thomas K Fehring 1,a, Keith A Fehring 1, Angela Hewlett 2, Carlos A Higuera 3, Jesse E Otero 1, Aaron J Tande 4
PMCID: PMC7431136  PMID: 32675671

This update on musculoskeletal infection presents a review of infection-related articles from January 2019 through April 2020, in English-language journals, located using the National Center for Biotechnology Information website, with a special emphasis on periprosthetic joint infection (PJI). The additional sections cover recent salient articles in the areas of spine, trauma, hand, and pediatrics.

Overview

While PJI remains a devastating complication for patient and surgeon alike, progress in diminishing its prevalence may be occurring through preoperative optimization, intraoperative strategies, and postoperative wound therapy. In a recent study using data from the National Surgical Quality Improvement Program (NSQIP), the authors evaluated the incidence of surgical site infections (SSIs) in the first 30 days following total hip arthroplasty (THA) in 2016 compared with the years 2012 to 20151. The greatest incidence of combined superficial and deep SSI was in 2012 (1.12%), while the lowest incidence was in 2016 (0.81%), a 28% decrease (p < 0.01). However, the incidence of deep infection was not significantly different between 2012 (0.30%) and 2016 (0.23%) (p = 0.153). Interpretation of these data must be tempered by the fact that they only reflect 30-day outcomes.

Mortality following PJI remains a serious issue. A systematic review of 19,169 patients with an average age of 65 years noted a 5-year mortality rate of 21%. The 1-year mortality risk was significantly higher than that for an aged-matched group of U.S. citizens (p < 0.001; odds ratio [OR], 3.58)2.

Treating patients with PJI is resource-intensive, requiring longer hospital stays and multidisciplinary treatment to ensure optimal results. An NSQIP database study compared resource utilization between 16,006 septic revision cases and 11,951 aseptic revisions. The authors found a significantly greater length of stay and rate of readmission, reoperation, and complications in the septic revision group (p < 0.001). As such, health policy-makers need to risk-adjust prospective payments to prevent the creation of disincentives to treat infected patients3.

Defining a successful result following the treatment of PJI remains elusive. In order to clarify this, the Musculoskeletal Infection Society (MSIS) convened a group to help define successful PJI treatment. They proposed a tiered system, with Tier 1 being infection control; Tier 2, infection control with suppressive antibiotics; Tier 3, need for reoperation and/or revision; and Tier 4, death. Use of this system will provide consistency in reporting and help to determine whether failure is directly or indirectly related to PJI4.

Prevention

The prevention of PJI after total joint arthroplasty (TJA) was a research topic of considerable interest in 2019. Articles generally focused on preoperative and intraoperative factors that affect PJI5. Several studies focused on the optimization of medical conditions prior to surgery to minimize infection risk. Two separate meta-analyses demonstrated a correlation of malnutrition with increased wound-healing and infection after arthroplasty (OR of 2.17 and 2.49 in the 2 studies, respectively)6,7. Prospective research will be required to determine whether correction of malnutrition normalizes PJI risk. Bedard and colleagues showed an increase in postoperative wound complications (OR, 1.78) and PJI (OR, 2.02) after TJA among tobacco users compared with nonusers in a meta-analysis of 14 studies8. In a study analyzing the data of U.S. veterans with hepatitis C in the TJA setting, it was shown that preoperative treatment of hepatitis C reduced the risk of postoperative infection roughly 2 to 3-fold after TJA9.

Perioperative antibiotic use is a powerful strategy for the prevention of PJI. In a retrospective study of 20,682 primary TJAs, the authors demonstrated through regression analysis that a single dose of preoperative intravenous (IV) antibiotics is as effective as 24 hours of perioperative dosing in the prevention of postoperative PJI10. Two other studies showed no benefit from the use of commercially available antibiotic-impregnated bone cement for total knee arthroplasty (TKA)11,12. Regarding local reduction of bacterial burden, Letzelter et al. presented a thorough review of different skin preparation solutions commonly utilized in orthopaedic surgery. They concluded that no consensus exists and that each area of the body may have its own microbiome, which may display different responses to the same skin antiseptic solution13. Goodman and colleagues demonstrated a higher prevalence of nasal methicillin-resistant Staphylococcus aureus (MRSA) carriage among patients with rheumatoid arthritis compared with controls, suggesting a possible explanation for higher infection rates postoperatively14.

Substantial effort has been dedicated to studying the effect of the operative environment on PJI. Results from the Mayo Clinic database called into question the idea that intraoperative dilute povidone-iodine irrigation is protective against PJI in both primary and revision TJA. In analyses of 11,738 primary and 2,884 revision cases, the authors found no difference in the rate of reoperation for infection at 3 and 12 months, comparing cases performed with and without the use of dilute povidone-iodine15,16. In a small-scale pilot study, Cook et al. showed a significant reduction in postoperative infection after primary TJA performed in an operating room with a supplemental ultraviolet-light-based air decontamination system17. In an observational study, Klaber et al. showed a low overall rate of bacterial contamination of surgical gowns during hip arthroplasty procedures, provided the operative time was <120 minutes, highlighting the importance of efficiency in the operating room18.

Surgical and patient factors have also been studied in relation to PJI after TJA. Taneja and colleagues showed that patients who received an allogeneic blood transfusion had a higher PJI risk compared with those who were not transfused19. Prolonged duration of surgery in primary TJA was shown to be associated with increased risk of PJI20, with a separate study showing an 18% increase in PJI for every 15 additional minutes in the operating room for primary TKA21. In a prospective randomized controlled trial, Newman and colleagues showed that patients undergoing revision TJA whose wounds were dressed with a negative-pressure device had a lower 12-week reoperation rate than those whose wounds were dressed with a standard dressing22. Keeney et al. showed similar early benefits in primary TJA dressed with a negative-pressure device, but there was no difference in longer-term PJI risk23.

Diagnosis of PJI

Shohat et al. validated an algorithm for diagnosing PJI using defined diagnostic criteria24; they defined PJI cases using only major MSIS criteria25 (n = 684) and, as a control, used aseptic revision cases that did not demonstrate failure for any reason within 2 years (n = 820). The algorithm was validated using a separate cohort (n = 422), showing a sensitivity of 97% and specificity of 99.5%. Unfortunately, the diagnosis of PJI within 6 weeks of the index arthroplasty is still elusive, as current accepted thresholds for synovial cell count and inflammatory markers have low sensitivity (<60%), especially in coagulase-negative Staphylococcus cases26. Likewise, Lazarides et al. showed that using inflammatory markers to diagnose PJI is not suitable for immunosuppressed patients, and newly described thresholds for synovial cell count and differential have better operative characteristics27. Moreover, Saleh et al. described how the evidence that has been used to set some of the diagnostic criteria is poor at best if analyzed using a validated Quality Assessment of Diagnostic Accuracy Studies tool, calling for better design in future studies28.

Joint Aspiration

Li et al. described a method to increase culture-positive yield when ≤1 mL of synovial fluid is aspirated: use of saline solution lavage (10 mL) and reaspiration of the joint. The samples were sent in 2 blood culture bottles for inoculation for 14 days in a BACT/ALERT 3D blood culture system (BioMérieux). The authors reported a sensitivity of 80% and specificity of 96%29. Likewise, measurement of synovial fluid viscosity may be a promising test to aid in PJI diagnosis, as it outperformed C-reactive protein (CRP) level and erythrocyte sedimentation rate (ESR), with a sensitivity of 93.3% and a specificity of 66.7%30.

Serum Biomarkers

D-dimer use for PJI diagnosis is still controversial, as Xu et al. demonstrated in a retrospective study. They found that CRP level, ESR, and interleukin (IL)-6 were diagnostically superior to D-dimer. Using an optimized threshold of 1.02 mg/L, the sensitivity of D-dimer was only 68%31.

Synovial Biomarkers

The alpha-defensin (AD) test continues to demonstrate diagnostic utility in particular scenarios. Among immunosuppressed patients, it demonstrated a sensitivity of 93% and a specificity of 100% in a retrospective study32. However, its use in reimplantation cases demonstrated low sensitivity33. Additionally, using Delphi-based criteria, at 1 year of follow-up34, 19.5% of the cases that had negative results prior to the second stage demonstrated treatment failure. Kleiss et al. also showed that the routine use of AD to evaluate painful hips or knees after arthroplasty is insufficient to accurately diagnose PJI, particularly in low-virulence infections35. However, the leukocyte esterase (LE) test was reported to be useful even in patients who were using antibiotics at the time of aspiration (sensitivity of 78%)36. Additionally, another study showed that the LE assay is better than or equivalent to frozen section histology (sensitivity and specificity of 100% and 93.8%, respectively, compared with 78.3% and 96.9%)37.

Molecular Diagnosis

Torchia et al. did a cost-effectiveness analysis of the use of next-generation sequencing and concluded that such a test should be reserved for clinical contexts with a high pretest probability of PJI38. In a multicenter study, polymerase chain reaction assay using restriction fragment length polymorphism to detect bacteria demonstrated a sensitivity and specificity of 97.4% and 100%, respectively39.

Imaging

The diagnostic accuracy of preoperative computed tomography (CT)-guided hip aspiration showed a sensitivity of 66.7% and a specificity of 98%40. Enlarged iliac lymph nodes and aspirated fluid volume of >1 mL were strong predictors of infection.

Treatment

Published research in the period of this review continued to clarify the role of each of the 3 major treatment options for PJI: irrigation and debridement, 2-stage exchange, and 1-stage exchange.

Irrigation and Debridement

Irrigation and debridement with component retention continues to show high failure rates (56%) even in the acute hematogenous setting with <3 weeks of symptoms41. A study looking at a 2-stage debridement protocol with component retention in 83 patients showed an 86.7% success rate of infection control with an average follow-up of 41 months42. This shows considerable improvement when compared with previously reported results of single-stage debridement with component retention.

The reported success rates for 2-stage exchange following a failed irrigation and debridement procedure remain variable. In a series of 291 knees with an average follow-up of 6.2 years, the success rate was 81% (51 of 63) in the direct staged revision group and 72% (159 of 221) in the failed irrigation and debridement group43.

Two-Stage Exchange

Recent studies have called into question the success rates of 2-stage exchange. A lack of infection control may lead to the need for an interim spacer exchange for a number of patients, with a rate of 16.9% (90 of 533) seen in 1 recent study44. Some patients may never undergo the second stage; a separate study found that to 18% (111 of 616) did not undergo reimplantation45. These groups of patients traditionally show higher rates of treatment failure and poor outcomes. Polymicrobial and fungal infections remain challenging to treat, with higher failure rates. In a recent study, polymicrobial infections were associated with lower treatment success, increased operative times, and longer hospitalizations when compared with single-organism infections46. In another study, fungal PJI resulted in a 61.5% failure rate with 2-stage exchange at an average of 33 months of follow-up47.

The results of a repeat 2-stage exchange for the treatment of recurrent knee infection was found to be largely dependent on MSIS grade, soft-tissue status, and the presence of an antibiotic-sensitive organism48. In this series, all MSIS type-C hosts became reinfected.

Different spacer types were examined in numerous studies. Articulating antibiotic spacers remain the standard for the interim treatment of PJI. However, static spacers showed comparable success rates in situations of severe bone loss, with an infection-eradication rate of 77%49. Primary TKA components with high-dose antibiotics are becoming increasingly popular for interim treatment. A multicenter study looking at these spacer types for definitive treatment showed a high rate of success, at 78.9% with minimum 2-year follow-up50. In 1 study, the addition of intramedullary dowels to antibiotic spacer constructs did not enhance infection eradication, despite their common use51.

One-Stage Exchange

While a prospective multicenter randomized study comparing 1-stage and 2-stage exchange is ongoing in the U.S., results are not yet available. However, 1-stage exchange continues to gain enthusiasm as treatment for PJI. A recent study examined 111 patients undergoing single-stage revision with cementless components for the treatment of chronic infection following THA. Ninety-nine (89.2%) of the patients were infection-free at a mean follow-up of 58 months52. Another study showed a 10-year rate of infection-free survival of 94% following 1-stage exchange for chronic PJI of the hip53. Which patients are good candidates for 1-stage exchange remains a question. In a study including 91 patients who had infection recurrence following 1-stage exchange TKA, risk factors for failure were identified. The authors found that a previous 1 or 2-stage exchange due to PJI and the isolation of Enterococcus or Streptococcus bacteria were associated with a higher risk of failure with 1-stage exchange54.

Antimicrobial Treatment

Vancomycin Powder

The use of vancomycin powder in various surgical procedures remains controversial. Two systematic reviews involving prophylactic vancomycin powder use in spine surgery demonstrated that the use of intrawound vancomycin powder significantly reduced the relative risk of developing a surgical site infection; however, there was significant heterogeneity among the studies reviewed55,56. Several other studies demonstrated reductions in deep and superficial SSIs with the use of intrawound vancomycin in spine surgery57. Caution should be exercised, however, since 1 meta-analysis found that spine patients who received intrawound vancomycin had less gram-positive SSIs but were twice as likely to develop a gram-negative or polymicrobial SSI compared with patients in the control group, and other studies demonstrated similar results58-60. A study using a rat model of spinal fusion found that local application of vancomycin may have an inhibitory effect on fusion61. Two systematic reviews and meta-analyses of intrawound vancomycin in extremity surgery as well as primary and revision arthroplasty58,62 demonstrated decreased rates of PJI; however, both studies recognized that only low-quality evidence exists. They both concluded that, before widespread adoption of this practice, large prospective randomized trials are necessary.

Oral Antibiotics in Primary and Revision Arthroplasty

A retrospective study and meta-analysis evaluated the clinical importance of a positive culture at reimplantation in 2-stage exchange arthroplasty. Pooled data of 11 studies showed a higher risk of failure among patients with a positive culture (OR, 4.58). Six weeks of antibiotic treatment following reimplantation decreased the odds of reinfection; however, the risk of reinfection remained 3 times higher for patients with a positive culture at reimplantation than for patients with a negative culture. The initial infecting organism did not match the organism isolated during reimplantation in 82.6% of the study population. There was also substantial heterogeneity in the antibiotic regimen and duration as well as in the protocols for 2-stage exchange, making interpretation difficult63.

A large randomized controlled trial evaluated oral versus IV antibiotics for the management of bone and joint infections and demonstrated that oral antibiotic therapy was noninferior to IV therapy for the treatment of bone and joint infections. The results of this study challenge the traditional management of bone and joint infections using IV antibiotics and may result in a change of clinical practice64.

The utility of an antibiotic-free period prior to reimplantation in 2-stage exchange arthroplasty was evaluated in a nonrandomized study, which demonstrated a higher cure rate in patients at 1 center who did not stop antibiotics prior to reimplantation compared with those at another center who discontinued antibiotics for 2 weeks. However, the methodology may reflect a comparison of treatment centers rather than antibiotic usage, making interpretation of the data difficult65.

Antibiotic Stewardship

A single-center study evaluated perioperative antibiotic choices for patients undergoing TJA. The risk of PJI was 32% lower among patients who received cefazolin compared with those who received other antimicrobial agents, emphasizing the importance of preoperative allergy testing in patients with stated beta-lactam allergies to ensure that patients receive optimal perioperative prophylaxis66. A review of regional and state antibiograms demonstrated that 75% of methicillin-sensitive S. aureus (MSSA) isolates and 60% of both MRSA and coagulase-negative Staphylococcus isolates were susceptible to clindamycin, whereas 99% of all isolates were susceptible to vancomycin67. These data can inform antibiotic choice for perioperative prophylaxis in patients with true penicillin allergies. The appropriateness of antibiotic prophylaxis prior to dental visits was assessed in a large study, using current guidelines as a reference, that included manipulation of the gingiva or tooth periapex. The authors found that >80% of antibiotics prescribed before dental visits for a variety of conditions (including TJA) are unnecessary68.

Antibiotic Complications and New Therapies

The incidence of Clostridium difficile colitis during inpatient hospital stays following revision TKA was found to be 1% and was associated with longer length of stay, higher costs, and greater mortality69. A case report demonstrated successful treatment of osteomyelitis due to an extensively drug-resistant organism with a combination of antibiotics and bacteriophages70.

Spine

Accurate microbiologic diagnosis is important for the management of native vertebral osteomyelitis (NVO). Unfortunately, CT-guided biopsy identified a pathogen in only 33% of cases, on the basis of a systematic review of 10 studies71. The findings of a separate observational study suggest that a repeat biopsy should be delayed by 3 days after the first, as approximately 75% of pathogens will be identified by that time72. There remains debate about the timing and necessity of surgical debridement or abscess drainage for NVO. In 1 observational study, early drainage of an epidural/paravertebral abscess provided a protective effect against disability or pain at 12 months73. A retrospective study that used propensity scoring to account for confounders found a trend toward pain reduction with a medical-surgical strategy compared with medical treatment alone74.

A large meta-analysis of SSI after spine surgery suggested an increased risk of infection among patients with diabetes, obesity, hypertension, prolonged operative time, and transfusion75. An observational study evaluated the impact of 5 preventive techniques on SSI rates: intrawound vancomycin powder, dilute Betadine (povidone-iodine) irrigation, preoperative chlorhexidine scrubs, preoperative nasal screening and decolonization of S. aureus, and perioperative antibiotic administration76. A notable reduction in pooled SSI rate, from 6% to 2%, was observed and was found to be highly cost-effective, despite variability in individual surgeon use of several of these strategies.

Pediatrics

The use of a clinical pathway to prevent SSI after posterior spinal fusion in high-risk children was evaluated in a recent study77. A marked decrease in deep SSI was observed, from 8% before to 1% after pathway implementation. Among children with acute hematogenous osteomyelitis (AHO), a clinical care algorithm was developed using formal quality-improvement methods and led to cost savings and improved empirical antimicrobial prescribing78. The validation and modification of a previously published severity of illness (SOI) score for AHO correlated well with several clinically meaningful surrogate measures79. Among a prospective cohort of children with AHO, a severe SOI score predicted osteonecrosis, chondrolysis, or deformity after 2 years of follow-up but did not predict functional outcomes80. Long-term, severe adverse outcomes occurred in 7.9% of children overall, but in only 1.3% of children with a mild SOI score, suggesting a way to tailor counseling and follow-up care.

Trauma

Infection after open fracture causes substantial morbidity in children and adults. However, there are little data directly comparing the frequency of infection between the 2 groups. A single-center cohort study found a significantly lower rate of infection among children than adults in patients with open tibial fracture81. Hypothesized reasons for the observed differences include the injury type, fixation devices used, or soft-tissue envelope.

The management of open reduction and internal fixation (ORIF)-associated infection is often extrapolated from the management of PJI, but it is a separate clinical entity. A 10-year series of consecutive ORIF-related infections demonstrated an overall failure rate of 11.7%82. While implant retention was successful for >85% of infections encountered ≤10 weeks after ORIF, failure occurred one-third of the time when late infections were encountered >10 weeks after ORIF.

Hand

The management of open fractures of the hand has traditionally been extrapolated from lower-extremity injury treatment or small, single-center studies. Utilizing the NSQIP database, open metacarpal, proximal, or middle phalangeal fractures were not associated with greater 30-day infection risk compared with closed fractures83. Furthermore, operative management of open fractures >1 day from presentation was not associated with increased risk of infection.

Conclusions

The prevention, diagnosis, and treatment of musculoskeletal infection remain challenging. Preoperative patient optimization and vigilance with regard to sterile technique are essential components of infection prevention. A high index of suspicion for the possibility of infection is critical when a patient with painful musculoskeletal symptoms presents. The appropriate use of currently available diagnostic tools is important for the clinician to fully understand. Collaborative decision-making between orthopaedic surgeons and infectious disease consultants is critical for success. Prompt intervention using evidence-based treatment guidelines should maximize results.

Evidence-Based Orthopaedics

The editorial staff of JBJS reviewed a large number of recently published studies related to the musculoskeletal system that received a higher Level of Evidence grade. In addition to articles cited already in this update, 6 other articles with a higher Level of Evidence grade were identified that were relevant to musculoskeletal infection. We have provided a brief commentary about each of the articles to help guide your further reading, in an evidence-based fashion, in this subspecialty area.

Evidence-Based Orthopaedics

Calkins TE, Culvern C, Nam D, Gerlinger TL, Levine BR, Sporer SM, Della Valle CJ. Dilute Betadine lavage reduces the risk of acute postoperative periprosthetic joint infection in aseptic revision total knee and hip arthroplasty: a randomized controlled trial. J Arthroplasty. 2020 Feb;35(2):538-543.e1. Epub 2019 Sep 12.

In this prospective randomized study of total hip and knee revisions, 478 patients received either dilute Betadine or normal saline solution lavage at the end of their procedure. There were 8 infections in the saline solution group (3.4%) and only 1 in the dilute Betadine group (0.4%). While these data are encouraging, there are a few caveats concerning their interpretation. A 3.4% infection rate is high and, without MSIS host classification being utilized, this trial is hard to interpret. Additionally, the dilute Betadine group had the skin edges prepared with Betadine at the time of closure, while the normal saline solution group did not. Whether or not this affected the results is not known.

Li M, Zeng Y, Wu Y, Si H, Bao X, Shen B. Performance of sequencing assays in diagnosis of prosthetic joint infection: a systematic review and meta-analysis. J Arthroplasty. 2019 Jul;34(7):1514-1522.e4. Epub 2019 Mar 7.

The authors conducted a systematic review and meta-analysis to assess the performance of multiple molecular diagnostic sequencing techniques in the diagnosis of PJI. The pooled sensitivity was 0.81, with a specificity of 0.94. Sequencing by synthesis seemed to be advantageous; however, receiving antibiotics before sampling decreased the sensitivity. While this technology is encouraging, challenges still exist concerning the frequent identification of falsely positive organisms. Other published studies have identified organisms through sequencing in aseptic synovial fluid taken from primary arthroplasties.

Mercurio M, Castioni D, Iannò B, Gasparini G, Galasso O. Outcomes of revision surgery after periprosthetic shoulder infection: a systematic review. J Shoulder Elbow Surg. 2019 Jun;28(6):1193-203. Epub 2019 Apr 16.

The authors evaluated 34 studies in a systematic review including 754 patients. They found that Cutibacterium acnes was the most common organism. The success rate was 96% for a 1-stage procedure, 93% for a permanent spacer, 86% for a 2-stage procedure, and 65% using irrigation and debridement for treatment. While the 1-stage data are encouraging, results could be influenced by selection bias. Healthier hosts may have undergone a 1-stage procedure, and less healthy hosts or patients with more virulent organisms may have undergone a 2-stage procedure. Therefore, a prospective randomized study with host classification would be necessary to determine superiority.

Mirza SZ, Richardson SS, Kahlenberg CA, Blevins JL, Lautenbach C, Demetres M, Martin L, Szymonifka J, Sculco PK, Figgie MP, Goodman SM. Diagnosing prosthetic joint infections in patients with inflammatory arthritis: a systematic literature review. J Arthroplasty. 2019 May;34(5):1032-1036.e2. Epub 2019 Jan 31.

The authors attempted to differentiate between septic and aseptic failure among patients with inflammatory arthritis. They reviewed 20 articles that met criteria. Five studies had pooled data for analysis. They reviewed 1,499 aseptic cases and compared them with 452 septic cases. While the most sensitive test was the percentage of neutrophils in aspirated material, the authors were unable to identify a biomarker to distinguish between aseptic and septic cases since disease activity was not specified in the available studies. Since serologic markers are an integral part of the diagnostic criteria to determine PJI, the influence of disease flares, which may increase serologic markers, and immune-modulating drugs, which may decrease serologic markers, makes this determination still problematic. Further research needs to be performed to clarify this issue.

Nene AM, Patil S, Kathare AP, Nagad P, Nene A, Kapadia F. Six versus 12 months of anti tubercular therapy in patients with biopsy proven spinal tuberculosis: a single center, open labeled, prospective randomized clinical trial-a pilot study. Spine (Phila Pa 1976). 2019 Jan 1;44(1):E1-6.

The authors of this prospective study attempted to determine the length of time necessary for antituberculous therapy in biopsy-proven tuberculosis of the spine. In this study of 100 patients, the authors concluded that antituberculous treatment of 6 months gave similar outcomes to a 12-month course, at 24 months of follow-up. This is an important study because there are no robust guidelines for the treatment of tuberculosis of the spine. There is only an extrapolation from pulmonary tuberculosis treatment. The results of this study may guide treatment, as prolonged antibiotic treatment may have the potential for the emergence of multidrug-resistant tuberculosis bacilli.

Zhang Z, Swanson WB, Wang YH, Lin W, Wang G. Infection-free rates and sequelae predict factors in bone transportation for infected tibia: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2018 Dec 13;19(1):442.

A systematic review of 22 studies including 518 patients evaluated the infection rate with external fixators versus hybrid fixators (combined internal and external fixators) in the treatment of infected tibial nonunion with bone transport. The infection rate was 14% in the hybrid-fixator group versus only 3% in the external-fixator group. Residual biofilm in internal fixators in the hybrid group after debridement may have played a role in this treatment disparity. However, extended use of external fixators leads to not only patient inconvenience but more joint stiffness and pin-track infections. Whether accelerated bone-transport techniques or antibiotic-coated internal-fixation devices could safely shorten external-fixator time remains to be determined.

Supplementary Material

SUPPLEMENTARY MATERIAL

Footnotes

Investigation performed at the OrthoCarolina Hip & Knee Center, Charlotte, North Carolina; University of Nebraska Medical Center, Omaha, Nebraska; Cleveland Clinic Florida, Weston, Florida; and Mayo Clinic, Rochester, Minnesota

Disclosure: The authors indicated that no external funding was received for any aspect of this work. On the Disclosure of Potential Conflicts of Interest forms, which are provided with the online version of the article, one or more of the authors checked “yes” to indicate that the author had a relevant financial relationship in the biomedical arena outside the submitted work (http://links.lww.com/JBJS/F907).

References

  • 1.Sodhi N, Anis HK, Garbarino LJ, Gold PA, Kurtz SM, Higuera CA, Hepinstall MS, Mont MA. Have we actually reduced our 30-day short-term surgical site infection rates in primary total hip arthroplasty in the United States? J Arthroplasty. 2019. September;34(9):2102-6. Epub 2019 Apr 26. [DOI] [PubMed] [Google Scholar]
  • 2.Natsuhara KM, Shelton TJ, Meehan JP, Lum ZC. Mortality during total hip periprosthetic joint infection. J Arthroplasty. 2019. July;34(7S):S337-42. Epub 2018 Dec 24. [DOI] [PubMed] [Google Scholar]
  • 3.Malik AT, Li M, Scharschmidt TJ, Khan SN. Revision of an infected total hip arthroplasty: the need for the adjustment of risk in bundled payment models for revision arthroplasty. Bone Joint J. 2019. May;101-B(5):547-51. [DOI] [PubMed] [Google Scholar]
  • 4.Fillingham YA, Della Valle CJ, Suleiman LI, Springer BD, Gehrke T, Bini SA, Segreti J, Chen AF, Goswami K, Tan TL, Shohat N, Diaz-Ledezma C, Schwartz AJ, Parvizi J. Definition of successful infection management and guidelines for reporting of outcomes after surgical treatment of periprosthetic joint infection: from the workgroup of the Musculoskeletal Infection Society (MSIS). J Bone Joint Surg Am. 2019. July 17;101(14):e69. [DOI] [PubMed] [Google Scholar]
  • 5.Elbuluk AM, Novikov D, Gotlin M, Schwarzkopf R, Iorio R, Vigdorchik J. Control strategies for infection prevention in total joint arthroplasty. Orthop Clin North Am. 2019. January;50(1):1-11. [DOI] [PubMed] [Google Scholar]
  • 6.Gu A, Malahias MA, Strigelli V, Nocon AA, Sculco TP, Sculco PK. Preoperative malnutrition negatively correlates with postoperative wound complications and infection after total joint arthroplasty: a systematic review and meta-analysis. J Arthroplasty. 2019. May;34(5):1013-24. Epub 2019 Jan 9. [DOI] [PubMed] [Google Scholar]
  • 7.Tsantes AG, Papadopoulos DV, Lytras T, Tsantes AE, Mavrogenis AF, Korompilias AV, Gelalis ID, Tsantes CG, Bonovas S. Association of malnutrition with periprosthetic joint and surgical site infections after total joint arthroplasty: a systematic review and meta-analysis. J Hosp Infect. 2019. September;103(1):69-77. Epub 2019 May 3. [DOI] [PubMed] [Google Scholar]
  • 8.Bedard NA, DeMik DE, Owens JM, Glass NA, DeBerg J, Callaghan JJ. Tobacco use and risk of wound complications and periprosthetic joint infection: a systematic review and meta-analysis of primary total joint arthroplasty procedures. J Arthroplasty. 2019. February;34(2):385-396.e4 Epub 2018 Oct 9. [DOI] [PubMed] [Google Scholar]
  • 9.Bendich I, Takemoto S, Patterson JT, Monto A, Barber TC, Kuo AC. Preoperative treatment of hepatitis C is associated with lower prosthetic joint infection rates in US veterans. J Arthroplasty. 2019. July;34(7S):S319: 326.e1. Epub 2019 Mar 9. [DOI] [PubMed] [Google Scholar]
  • 10.Tan TL, Shohat N, Rondon AJ, Foltz C, Goswami K, Ryan SP, Seyler TM, Parvizi J. Perioperative antibiotic prophylaxis in total joint arthroplasty: a single dose is as effective as multiple doses. J Bone Joint Surg Am. 2019. March 6;101(5):429-37. [DOI] [PubMed] [Google Scholar]
  • 11.Anis HK, Sodhi N, Faour M, Klika AK, Mont MA, Barsoum WK, Higuera CA, Molloy RM. Effect of antibiotic-impregnated bone cement in primary total knee arthroplasty. J Arthroplasty. 2019. September;34(9):2091-2095.e1. Epub 2019 Apr 22. [DOI] [PubMed] [Google Scholar]
  • 12.Sultan AA, Samuel LT, Umpierrez E, Swiergosz A, Rabin J, Mahmood B, Mont MA. Routine use of commercial antibiotic-loaded bone cement in primary total joint arthroplasty: a critical analysis of the current evidence. Ann Transl Med. 2019. February;7(4):73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Letzelter J, Hill JB, Hacquebord J. An overview of skin antiseptics used in orthopaedic surgery procedures. J Am Acad Orthop Surg. 2019. August 15;27(16):599-606. [DOI] [PubMed] [Google Scholar]
  • 14.Goodman SM, Nocon AA, Selemon NA, Shopsin B, Fulmer Y, Decker ME, Grond SE, Donlin LT, Figgie MP, Sculco TP, Russell LA, Henry ME, Bass AR, Miller AO, Sculco PK. Increased Staphylococcus aureus nasal carriage rates in rheumatoid arthritis patients on biologic therapy. J Arthroplasty. 2019. May;34(5):954-8. Epub 2019 Jan 17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Hart A, Hernandez NM, Abdel MP, Mabry TM, Hanssen AD, Perry KI. Povidone-iodine wound lavage to prevent infection after revision total hip and knee arthroplasty: an analysis of 2,884 cases. J Bone Joint Surg Am. 2019. July 3;101(13):1151-9. [DOI] [PubMed] [Google Scholar]
  • 16.Hernandez NM, Hart A, Taunton MJ, Osmon DR, Mabry TM, Abdel MP, Perry KI. Use of povidone-iodine irrigation prior to wound closure in primary total hip and knee arthroplasty: an analysis of 11,738 cases. J Bone Joint Surg Am. 2019. July 3;101(13):1144-50. [DOI] [PubMed] [Google Scholar]
  • 17.Cook TM, Piatt CJ, Barnes S, Edmiston CE., Jr The impact of supplemental intraoperative air decontamination on the outcome of total joint arthroplasty: a pilot analysis. J Arthroplasty. 2019. March;34(3):549-53. Epub 2018 Dec 7. [DOI] [PubMed] [Google Scholar]
  • 18.Klaber I, Ruiz P, Schweitzer D, Lira MJ, Botello E, Wozniak A. Contamination rate of the surgical gowns during total hip arthroplasty. Arch Orthop Trauma Surg. 2019. July;139(7):1015-9. Epub 2019 May 24. [DOI] [PubMed] [Google Scholar]
  • 19.Taneja A, El-Bakoury A, Khong H, Railton P, Sharma R, Johnston KD, Puloski S, Smith C, Powell J. Association between allogeneic blood transfusion and wound infection after total hip or knee arthroplasty: a retrospective case-control study. J Bone Jt Infect. 2019. April 20;4(2):99-105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Wang Q, Goswami K, Shohat N, Aalirezaie A, Manrique J, Parvizi J. Longer operative time results in a higher rate of subsequent periprosthetic joint infection in patients undergoing primary joint arthroplasty. J Arthroplasty. 2019. May;34(5):947-53. Epub 2019 Jan 18. [DOI] [PubMed] [Google Scholar]
  • 21.Anis HK, Sodhi N, Klika AK, Mont MA, Barsoum WK, Higuera CA, Molloy RM. Is operative time a predictor for post-operative infection in primary total knee arthroplasty? J Arthroplasty. 2019. July;34(7S):S331-6. Epub 2018 Nov 22. [DOI] [PubMed] [Google Scholar]
  • 22.Newman JM, Siqueira MBP, Klika AK, Molloy RM, Barsoum WK, Higuera CA. Use of closed incisional negative pressure wound therapy after revision total hip and knee arthroplasty in patients at high risk for infection: a prospective, randomized clinical trial. J Arthroplasty. 2019. March;34(3):554-559.e1. Epub 2018 Nov 17. [DOI] [PubMed] [Google Scholar]
  • 23.Keeney JA, Cook JL, Clawson SW, Aggarwal A, Stannard JP. Incisional negative pressure wound therapy devices improve short-term wound complications, but not long-term infection rate following hip and knee arthroplasty. J Arthroplasty. 2019. April;34(4):723-8. Epub 2018 Dec 15. [DOI] [PubMed] [Google Scholar]
  • 24.Shohat N, Tan TL, Della Valle CJ, Calkins TE, George J, Higuera C, Parvizi J. Development and validation of an evidence-based algorithm for diagnosing periprosthetic joint infection. J Arthroplasty. 2019. November;34(11):2730-2736.e1. Epub 2019 Jun 13. [DOI] [PubMed] [Google Scholar]
  • 25.Parvizi J, Zmistowski B, Berbari EF, Bauer TW, Springer BD, Della Valle CJ, Garvin KL, Mont MA, Wongworawat MD, Zalavras CG. New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res. 2011. November;469(11):2992-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Xu C, Tan TL, Kuo FC, Goswami K, Wang Q, Parvizi J. Reevaluating current cutoffs for acute periprosthetic joint infection: current thresholds are insensitive. J Arthroplasty. 2019. November;34(11):2744-8. Epub 2019 Jun 27. [DOI] [PubMed] [Google Scholar]
  • 27.Lazarides AL, Vovos TJ, Reddy GB, Kildow BJ, Wellman SS, Jiranek WA, Seyler TM. Traditional laboratory markers hold low diagnostic utility for immunosuppressed patients with periprosthetic joint infections. J Arthroplasty. 2019. July;34(7):1441-5. Epub 2019 Mar 12. [DOI] [PubMed] [Google Scholar]
  • 28.Saleh A, George J, Sultan AA, Samuel LT, Mont MA, Higuera-Rueda CA. The quality of diagnostic studies in periprosthetic joint infections: can we do better? J Arthroplasty. 2019. November;34(11):2737-43. Epub 2019 Jun 27. [DOI] [PubMed] [Google Scholar]
  • 29.Li R, Lu Q, Chai W, Hao LB, Lu SB, Chen JY. Saline solution lavage and reaspiration for culture with a blood culture system is a feasible method for diagnosing periprosthetic joint infection in patients with insufficient synovial fluid. J Bone Joint Surg Am. 2019. June 5;101(11):1004-9. [DOI] [PubMed] [Google Scholar]
  • 30.Fu J, Ni M, Chai W, Li X, Hao L, Chen J. Synovial fluid viscosity test is promising for the diagnosis of periprosthetic joint infection. J Arthroplasty. 2019. June;34(6):1197-200. Epub 2019 Feb 13. [DOI] [PubMed] [Google Scholar]
  • 31.Xu H, Xie J, Huang Q, Lei Y, Zhang S, Pei F. Plasma fibrin degradation product and D-dimer are of limited value for diagnosing periprosthetic joint infection. J Arthroplasty. 2019. October;34(10):2454-60. Epub 2019 May 13. [DOI] [PubMed] [Google Scholar]
  • 32.Miyamae Y, George J, Klika AK, Barsoum WK, Higuera CA. Diagnostic accuracy of the alpha-defensin test for periprosthetic joint infection in patients with inflammatory diseases. J Arthroplasty. 2019. August;34(8):1767-71. Epub 2019 Apr 13. [DOI] [PubMed] [Google Scholar]
  • 33.Stone WZ, Gray CF, Parvataneni HK, Prieto HA. Clinical evaluation of alpha defensin test following staged treatment of prosthetic joint infections. J Arthroplasty. 2019. July;34(7):1446-51. Epub 2019 Mar 13. [DOI] [PubMed] [Google Scholar]
  • 34.Diaz-Ledezma C, Higuera CA, Parvizi J. Success after treatment of periprosthetic joint infection: a Delphi-based international multidisciplinary consensus. Clin Orthop Relat Res. 2013. July;471(7):2374-82. Epub 2013 Feb 26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Kleiss S, Jandl NM, Novo de Oliveira A, Rüther W, Niemeier A. Diagnostic accuracy of alpha-defensin enzyme-linked immunosorbent assay in the clinical evaluation of painful hip and knee arthroplasty with possible prosthetic joint infection: a prospective study of 202 cases. Bone Joint J. 2019. August;101-B(8):970-7. [DOI] [PubMed] [Google Scholar]
  • 36.Shahi A, Alvand A, Ghanem E, Restrepo C, Parvizi J. The leukocyte esterase test for periprosthetic joint infection is not affected by prior antibiotic administration. J Bone Joint Surg Am. 2019. April 17;101(8):739-44. [DOI] [PubMed] [Google Scholar]
  • 37.Zagra L, Villa F, Cappelletti L, Gallazzi E, Materazzi G, De Vecchi E. Can leucocyte esterase replace frozen sections in the intraoperative diagnosis of prosthetic hip infection? Bone Joint J. 2019. April;101-B(4):372-7. [DOI] [PubMed] [Google Scholar]
  • 38.Torchia MT, Austin DC, Kunkel ST, Dwyer KW, Moschetti WE. Next-generation sequencing vs culture-based methods for diagnosing periprosthetic joint infection after total knee arthroplasty: a cost-effectiveness analysis. J Arthroplasty. 2019. July;34(7):1333-41. Epub 2019 Mar 19. [DOI] [PubMed] [Google Scholar]
  • 39.Moshirabadi A, Razi M, Arasteh P, Sarzaeem MM, Ghaffari S, Aminiafshar S, Hosseinian Khosroshahy K, Sheikholeslami FM. Polymerase chain reaction assay using the restriction fragment length polymorphism technique in the detection of prosthetic joint infections: a multi-centered study. J Arthroplasty. 2019. February;34(2):359-64. Epub 2018 Oct 25. [DOI] [PubMed] [Google Scholar]
  • 40.Isern-Kebschull J, Tomas X, García-Díez AI, Morata L, Ríos J, Soriano A. Accuracy of computed tomography-guided joint aspiration and computed tomography findings for prediction of infected hip prosthesis. J Arthroplasty. 2019. August;34(8):1776-82. Epub 2019 Apr 12. [DOI] [PubMed] [Google Scholar]
  • 41.Shohat N, Goswami K, Tan TL, Fillingham Y, Parvizi J. Increased failure after irrigation and debridement for acute hematogenous periprosthetic joint infection. J Bone Joint Surg Am. 2019. April 17;101(8):696-703. [DOI] [PubMed] [Google Scholar]
  • 42.Chung AS, Niesen MC, Graber TJ, Schwartz AJ, Beauchamp CP, Clarke HD, Spangehl MJ. Two-stage debridement with prosthesis retention for acute periprosthetic joint infections. J Arthroplasty. 2019. June;34(6):1207-13. Epub 2019 Feb 16. [DOI] [PubMed] [Google Scholar]
  • 43.Kim K, Zhu M, Cavadino A, Munro JT, Young SW. Failed debridement and implant retention does not compromise the success of subsequent staged revision in infected total knee arthroplasty. J Arthroplasty. 2019. June;34(6):1214-1220.e1. Epub 2019 Feb 2. [DOI] [PubMed] [Google Scholar]
  • 44.Tan TL, Goswami K, Kheir MM, Xu C, Wang Q, Parvizi J. Surgical treatment of chronic periprosthetic joint infection: fate of spacer exchanges. J Arthroplasty. 2019. September;34(9):2085-2090.e1. Epub 2019 Apr 12. [DOI] [PubMed] [Google Scholar]
  • 45.Wang Q, Goswami K, Kuo FC, Xu C, Tan TL, Parvizi J. Two-stage exchange arthroplasty for periprosthetic joint infection: the rate and reason for the attrition after the first stage. J Arthroplasty. 2019. November;34(11):2749-56. Epub 2019 Jun 15. [DOI] [PubMed] [Google Scholar]
  • 46.Kavolus JJ, Cunningham DJ, Rao SR, Wellman SS, Seyler TM. Polymicrobial infections in hip arthroplasty: lower treatment success rate, increased surgery, and longer hospitalization. J Arthroplasty. 2019. April;34(4):710-716.e3. Epub 2018 Oct 9. [DOI] [PubMed] [Google Scholar]
  • 47.Theil C, Schmidt-Braekling T, Gosheger G, Idelevich EA, Moellenbeck B, Dieckmann R. Fungal prosthetic joint infection in total hip or knee arthroplasty: a retrospective single-centre study of 26 cases. Bone Joint J. 2019. May;101-B(5):589-95. [DOI] [PubMed] [Google Scholar]
  • 48.Vadiee I, Backstein DJ. The effectiveness of repeat two-stage revision for the treatment of recalcitrant total knee arthroplasty infection. J Arthroplasty. 2019. February;34(2):369-74. Epub 2018 Oct 25. [DOI] [PubMed] [Google Scholar]
  • 49.Hipfl C, Winkler T, Janz V, Perka C, Müller M. Management of chronically infected total knee arthroplasty with severe bone loss using static spacers with intramedullary rods. J Arthroplasty. 2019. July;34(7):1462-9. Epub 2019 Mar 29. [DOI] [PubMed] [Google Scholar]
  • 50.Siddiqi A, Nace J, George NE, Buxbaum EJ, Ong AC, Orozco FR, Ponzio DY, Post ZD. Primary total knee arthroplasty implants as functional prosthetic spacers for definitive management of periprosthetic joint infection: a multicenter study. J Arthroplasty. 2019. December;34(12):3040-7. Epub 2019 Jul 11. [DOI] [PubMed] [Google Scholar]
  • 51.Zielinski MR, Ziemba-Davis M, Warth LC, Keyes BJ, Meneghini RM. Do antibiotic intramedullary dowels assist in eradicating infection in two-stage resection for septic total knee arthroplasty? J Arthroplasty. 2019. October;34(10):2461-5. Epub 2019 May 16. [DOI] [PubMed] [Google Scholar]
  • 52.Ji B, Wahafu T, Li G, Zhang X, Wang Y, Momin M, Cao L. Single-stage treatment of chronically infected total hip arthroplasty with cementless reconstruction: results in 126 patients with broad inclusion criteria. Bone Joint J. 2019. April;101-B(4):396-402. [DOI] [PubMed] [Google Scholar]
  • 53.Zahar A, Klaber I, Gerken AM, Gehrke T, Gebauer M, Lausmann C, Citak M. Ten-year results following one-stage septic hip exchange in the management of periprosthetic joint infection. J Arthroplasty. 2019. June;34(6):1221-6. Epub 2019 Feb 20. [DOI] [PubMed] [Google Scholar]
  • 54.Citak M, Friedenstab J, Abdelaziz H, Suero EM, Zahar A, Salber J, Gehrke T. Risk factors for failure after 1-stage exchange total knee arthroplasty in the management of periprosthetic joint infection. J Bone Joint Surg Am. 2019. June 19;101(12):1061-9. [DOI] [PubMed] [Google Scholar]
  • 55.Dodson V, Majmundar N, Swantic V, Assina R. The effect of prophylactic vancomycin powder on infections following spinal surgeries: a systematic review. Neurosurg Focus. 2019. January 1;46(1):E11. [DOI] [PubMed] [Google Scholar]
  • 56.Sadigursky D, Sousa MD, Cajaíba YGL, Martins RR, Lobão DMV. Infectious prophylaxis with intrawound vancomycin powder in orthopedic surgeries: systematic review with meta-analysis. Rev Bras Ortop (Sao Paulo). 2019. December;54(6):617-26. Epub 2019 Sep 23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Lemans JVC, Öner FC, Wijdicks SPJ, Ekkelenkamp MB, Vogely HC, Kruyt MC. The efficacy of intrawound vancomycin powder and povidone-iodine irrigation to prevent surgical site infections in complex instrumented spine surgery. Spine J. 2019. October;19(10):1648-56. Epub 2019 May 31. [DOI] [PubMed] [Google Scholar]
  • 58.Gande A, Rosinski A, Cunningham T, Bhatia N, Lee YP. Selection pressures of vancomycin powder use in spine surgery: a meta-analysis. Spine J. 2019. June;19(6):1076-84. Epub 2019 Jan 17. [DOI] [PubMed] [Google Scholar]
  • 59.Grabel ZJ, Boden A, Segal DN, Boden S, Milby AH, Heller JG. The impact of prophylactic intraoperative vancomycin powder on microbial profile, antibiotic regimen, length of stay, and reoperation rate in elective spine surgery. Spine J. 2019. February;19(2):261-6. Epub 2018 May 31. [DOI] [PubMed] [Google Scholar]
  • 60.Khanna K, Valone F, 3rd, Tenorio A, Grace T, Burch S, Berven S, Tay B, Deviren V, Hu SS. Local application of vancomycin in spine surgery does not result in increased vancomycin-resistant bacteria-10-year data. Spine Deform. 2019. September;7(5):696-701. Epub 2019 Dec 30. [DOI] [PubMed] [Google Scholar]
  • 61.Ishida W, Perdomo-Pantoja A, Elder BD, Locke J, Holmes C, Witham TF, Lo SL. Effects of intraoperative intrawound antibiotic administration on spinal fusion: a comparison of vancomycin and tobramycin in a rat model. J Bone Joint Surg Am. 2019. October 2;101(19):1741-9. [DOI] [PubMed] [Google Scholar]
  • 62.Heckmann ND, Mayfield CK, Culvern CN, Oakes DA, Lieberman JR, Della Valle CJ. Systematic review and meta-analysis of intrawound vancomycin in total hip and total knee arthroplasty: a call for a prospective randomized trial. J Arthroplasty. 2019. August;34(8):1815-22. Epub 2019 Apr 1. [DOI] [PubMed] [Google Scholar]
  • 63.Xu C, Tan TL, Chen JY. Positive culture during reimplantation increases the risk of reinfection in two-stage exchange arthroplasty despite administrating prolonged antibiotics: a retrospective cohort study and meta-analysis. J Arthroplasty. 2019. May;34(5):1025-31. Epub 2019 Jan 24. [DOI] [PubMed] [Google Scholar]
  • 64.Li HK, Rombach I, Zambellas R, Walker AS, McNally MA, Atkins BL, Lipsky BA, Hughes HC, Bose D, Kümin M, Scarborough C, Matthews PC, Brent AJ, Lomas J, Gundle R, Rogers M, Taylor A, Angus B, Byren I, Berendt AR, Warren S, Fitzgerald FE, Mack DJF, Hopkins S, Folb J, Reynolds HE, Moore E, Marshall J, Jenkins N, Moran CE, Woodhouse AF, Stafford S, Seaton RA, Vallance C, Hemsley CJ, Bisnauthsing K, Sandoe JAT, Aggarwal I, Ellis SC, Bunn DJ, Sutherland RK, Barlow G, Cooper C, Geue C, McMeekin N, Briggs AH, Sendi P, Khatamzas E, Wangrangsimakul T, Wong THN, Barrett LK, Alvand A, Old CF, Bostock J, Paul J, Cooke G, Thwaites GE, Bejon P, Scarborough M; OVIVA Trial Collaborators. Oral versus intravenous antibiotics for bone and joint infection. N Engl J Med. 2019. January 31;380(5):425-36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Ascione T, Balato G, Mariconda M, Rotondo R, Baldini A, Pagliano P. Continuous antibiotic therapy can reduce recurrence of prosthetic joint infection in patients undergoing 2-stage exchange. J Arthroplasty. 2019. April;34(4):704-9. Epub 2018 Dec 20. [DOI] [PubMed] [Google Scholar]
  • 66.Wyles CC, Hevesi M, Osmon DR, Park MA, Habermann EB, Lewallen DG, Berry DJ, Sierra RJ. 2019 John Charnley Award: Increased risk of prosthetic joint infection following primary total knee and hip arthroplasty with the use of alternative antibiotics to cefazolin: the value of allergy testing for antibiotic prophylaxis. Bone Joint J. 2019. June;101-B(6_Supple_B):9-15. [DOI] [PubMed] [Google Scholar]
  • 67.Nodzo SR, Boyle KK, Frisch NB. Nationwide organism susceptibility patterns to common preoperative prophylactic antibiotics: what are we covering? J Arthroplasty. 2019. July;34(7S):S302-6. Epub 2019 Jan 17. [DOI] [PubMed] [Google Scholar]
  • 68.Suda KJ, Calip GS, Zhou J, Rowan S, Gross AE, Hershow RC, Perez RI, McGregor JC, Evans CT. Assessment of the appropriateness of antibiotic prescriptions for infection prophylaxis before dental procedures, 2011 to 2015. JAMA Netw Open. 2019. May 3;2(5):e193909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Gwam CU, George NE, Etcheson JI, Tarazi JM, Han GR, Griffith KME, Mont MA, Delanois RE. Clostridium difficile infection in the USA: incidence and associated factors in revision total knee arthroplasty patients. Eur J Orthop Surg Traumatol. 2019. April;29(3):667-74. Epub 2018 Oct 22. [DOI] [PubMed] [Google Scholar]
  • 70.Nir-Paz R, Gelman D, Khouri A, Sisson BM, Fackler J, Alkalay-Oren S, Khalifa L, Rimon A, Yerushalmy O, Bader R, Amit S, Coppenhagen-Glazer S, Henry M, Quinones J, Malagon F, Biswas B, Moses AE, Merril G, Schooley RT, Brownstein MJ, Weil YA, Hazan R. Successful treatment of antibiotic-resistant, poly-microbial bone infection with bacteriophages and antibiotics combination. Clin Infect Dis. 2019. November 13;69(11):2015-8. [DOI] [PubMed] [Google Scholar]
  • 71.Sertic M, Parkes L, Mattiassi S, Pritzker K, Gardam M, Murphy K. The efficacy of computed tomography-guided percutaneous spine biopsies in determining a causative organism in cases of suspected infection: a systematic review. Can Assoc Radiol J. 2019. February;70(1):96-103. [DOI] [PubMed] [Google Scholar]
  • 72.Yeh KJ, Husseini JS, Hemke R, Nelson SB, Chang CY. CT-guided discitis-osteomyelitis biopsies with negative microbiology: how many days should we wait before repeating the biopsy? Skeletal Radiol. 2020. April;49(4):619-23. Epub 2019 Nov 23. [DOI] [PubMed] [Google Scholar]
  • 73.Lee YM, Cho OH, Park SY, Moon C, Chong YP, Kim SH, Lee SO, Choi SH, Lee MS, Bae IG, Kim YS, Woo JH, Kang KC, Lee JH, Park KH. Factors associated with sequelae after treatment of hematogenous pyogenic vertebral osteomyelitis. Diagn Microbiol Infect Dis. 2019. May;94(1):66-72. Epub 2018 Dec 4. [DOI] [PubMed] [Google Scholar]
  • 74.Canouï E, Zarrouk V, Canouï-Poitrine F, Desmoulin U, Leflon V, Allaham W, de Lastours V, Guigui P, Fantin B. Surgery is safe and effective when indicated in the acute phase of hematogenous pyogenic vertebral osteomyelitis. Infect Dis (Lond). 2019. April;51(4):268-76. Epub 2019 Feb 7. [DOI] [PubMed] [Google Scholar]
  • 75.Peng XQ, Sun CG, Fei ZG, Zhou QJ. Risk factors for surgical site infection after spinal surgery: a systematic review and meta-analysis based on twenty-seven studies. World Neurosurg. 2019. March;123:e318-29. Epub 2018 Nov 26. [DOI] [PubMed] [Google Scholar]
  • 76.Tomov M, Wanderman N, Berbari E, Currier B, Yaszemski M, Nassr A, Huddleston P, Bydon M, Freedman B. An empiric analysis of 5 counter measures against surgical site infections following spine surgery-a pragmatic approach and review of the literature. Spine J. 2019. February;19(2):267-75. Epub 2018 Jun 2. [DOI] [PubMed] [Google Scholar]
  • 77.Glotzbecker M, Troy M, Miller P, Berry J, Cohen L, Gryzwna A, McCann ME, Hresko MT, Goobie S, Emans J, Brustowitz R, Snyder B, Hedequist D. Implementing a multidisciplinary clinical pathway can reduce the deep surgical site infection rate after posterior spinal fusion in high-risk patients. Spine Deform. 2019. January;7(1):33-9. Epub 2019 Dec 30. [DOI] [PubMed] [Google Scholar]
  • 78.Robinette ED, Brower L, Schaffzin JK, Whitlock P, Shah SS, Connelly B; AHO Care Algorithm Team. Use of a clinical care algorithm to improve care for children with hematogenous osteomyelitis. Pediatrics. 2019. January;143(1):e20180387. [DOI] [PubMed] [Google Scholar]
  • 79.Athey AG, Mignemi ME, Gheen WT, Lindsay EA, Jo CH, Copley LA. Validation and modification of a severity of illness score for children with acute hematogenous osteomyelitis. J Pediatr Orthop. 2019. February;39(2):90-7. [DOI] [PubMed] [Google Scholar]
  • 80.Vorhies JS, Lindsay EA, Tareen NG, Kellum RJ, Jo CH, Copley LA. Severity adjusted risk of long-term adverse sequelae among children with osteomyelitis. Pediatr Infect Dis J. 2019. January;38(1):26-31. [DOI] [PubMed] [Google Scholar]
  • 81.Chen H, Chen S, Shi Y, Lu Y, Yu B. Children with open tibial fractures show significantly lower infection rates than adults: clinical comparative study. Int Orthop. 2019. March;43(3):713-8. Epub 2018 May 28. [DOI] [PubMed] [Google Scholar]
  • 82.Kuehl R, Tschudin-Sutter S, Morgenstern M, Dangel M, Egli A, Nowakowski A, Suhm N, Theilacker C, Widmer AF. Time-dependent differences in management and microbiology of orthopaedic internal fixation-associated infections: an observational prospective study with 229 patients. Clin Microbiol Infect. 2019. January;25(1):76-81. Epub 2018 Apr 10. [DOI] [PubMed] [Google Scholar]
  • 83.Minhas SV, Catalano LW., 3rd Comparison of open and closed hand fractures and the effect of urgent operative intervention. J Hand Surg Am. 2019. January;44(1):65–e1.-7. Epub 2018 Jun 13. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

SUPPLEMENTARY MATERIAL

Articles from The Journal of Bone and Joint Surgery. American Volume are provided here courtesy of Wolters Kluwer Health

RESOURCES